Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Carmat SA Announces Agreement with the Prince Sultan Cardiac Center in Riyadh, Kingdom of Saudi Arabia, to Perform Implants of Carmat's Bioprosthetic Artificial Heart


Monday, 20 May 2013 11:45am EDT 

Carmat SA announced that Prince Sultan Cardiac Center (PSCC) in Riyadh, Kingdom of Saudi Arabia, has agreed to participate into the first clinical implants of Carmat bioprosthetic artificial heart. The patient selection process is being finalized and the training of the surgical and medical teams at PSCC has started. Implantations could start following the completion of the training. 

Latest Developments for Carmat SA

Company Quote

72.92
0.18 +0.25%
22 Oct 2014